ECE2008 Poster Presentations Adrenal (61 abstracts)
The German Conn's registry: comorbidities in over 700 patients with primary hyperaldosteronism
Eric Born-Frontsberg 1 , Caroline Schirpenbach 2 , Stefanie Hahner 3 , Felix Beuschlein 2 , Martin Bidlingmaier 2 , Sven Diederich 4 , R Lorenz 5 , Lars Rump 6 , Jochen Seufert 7 , Stefan Endres 2 , Marcus Quinkler 1 & Martin Reincke 2
1Klinische Endokrinologie, Charité Campus Mitte, Charite Universitätsmedizin Berlin, Berlin, Germany; 2Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München, München, Germany; 3Medizinische Klinik und Poliklinik I, Julius-Maximilians-Universität, Würzburg, Germany; 4Endokrinologikum Berlin, Berlin, Germany; 5Institut für Prophylaxe und Epidemiologie der Kreislaufkrankheiten, Ludwig-Maximilians-Universität München, München, Germany; 6Marienhospital, Ruhr-Universität Bochum, Herne, Germany; 7Medizinische Klinik II, Albert-Ludwigs-Universität, Freiburg, Germany.
Objective: Hypokalemic Conn’s syndrome is a rare disease with a prevalence of 0.5% in unselected hypertensive populations. However, recent studies indicate a higher prevalence of a milder variant of Conn’s syndrome, reaching 10% in some studies. Long term outcome and health care costs of hypo- and normokalemic variants are largely unknown. The National Conn’s Registry is an initiative to create a national database of sufficient epidemiological strength to investigate co-morbidity and mortality in these patients.
Methods: The registry has at present 7 participating centres in 5 locations and uses an electronic database to assure comparison of different centres. Since 07/2006 retrospective data were included in the database from patients with Conn’s syndrome diagnosed between 1990 and 2007.
Results: Evaluation of the retrospective data entry provide the following results: Of the 726 patients (60.4±13.7 years, range 6–96 years), 54.3% had the hypokalemic variant of the disease. The mean RR was 158±29 mmHg systolic and 94±16 mmHg diastolic. Morbidity of cerebrovascular events (TIA, PRIND, stroke) in the overall cohort was high with 9.6% of patients. The prevalence of cardiovascular morbidity (angina pectoris, myocardial infarction, coronary angioplasty) was 13.5% in our cohort. Atrial fibrillation occurred in 8.4% of the patients and other atrial or ventricular dysrhythmia in 5.5% of the patients. Chronic renal failure was present in 10.9% of patients, and sleep apnea in 8.1% of patients. Overall co-morbidities were more frequent in hypokalemic than in normokalemic individuals.
Conclusion: Our data show high proportion co-morbidites for Conn’s syndrome, which is endorsed by previous results from France describing a 3–4 fold higher prevalence of stroke, myocardial infarction and atrial fibrillation in a small cohort of primary aldosteronism (n=124) compared to patients with essential hypertension (n=465). In addition, our data demonstrate evidence that the hypokalemic variant of Conn’s syndrome has a higher morbidity than the normokalemic variant.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more